Web-based Assessment of Autoimmune Immune-Mediated and Rheumatic Patients during the COVID-19 Pandemic (WARCOV)

Brief description of study

The purpose of this study is to monitor the condition of patients with autoimmune diseases (such as rheumatoid arthritis, psoriatic arthritis, psoriasis, inflammatory bowel disease, or ankylosing spondylitis) during the 2019-2020 novel coronavirus (COVID-19) pandemic. Because this type of virus has never been encountered before, we do not have any information on how autoimmune disease and the medications that will be used for treatment will influence susceptibility to COVID-19 and the disease course of those who are infected.




If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.